Compare Medpace Holdings Inc (MEDP) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Medpace Holdings Inc trades at $533.39 (market cap $15.08B), while GraniteShares 2x Long NVDA Daily ETF trades at $31.1. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, GraniteShares 2x Long NVDA Daily ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | NVDL | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $620.59 | $43.02 |
52-Week Low | $308.88 | $21.76 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $30.51 with a 0.76% daily gain. The technical outlook is bearish with moving averages signaling selling pressure, while oscillators remain neutral. Recent news highlights the fund's volatility, including a 12% single-day drop on June 5, 2026, and a 67% decline in early 2025, underscoring the risks of daily leverage reset mechanics.
The outlook for NVDL is heavily tied to NVIDIA's performance and AI sector momentum. While the ETF has delivered strong returns year-to-date (up 12.66% as of June 8, 2026), its leveraged structure amplifies both gains and losses. Key risks include NVIDIA's earnings volatility, broader semiconductor market swings, and the compounding effect of daily resets during downtrends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
